Search filters

List of works by Devyani Deshpande

A 'shock and awe' thioridazine and moxifloxacin combination-based regimen for pulmonary Mycobacterium avium-intracellulare complex disease

scientific article published on September 2017

A Combination Regimen Design Program Based on Pharmacodynamic Target Setting for Childhood Tuberculosis: Design Rules for the Playground

scientific article

A Faropenem, Linezolid, and Moxifloxacin Regimen for Both Drug-Susceptible and Multidrug-Resistant Tuberculosis in Children: FLAME Path on the Milky Way.

scientific article

A Long-term Co-perfused Disseminated Tuberculosis-3D Liver Hollow Fiber Model for Both Drug Efficacy and Hepatotoxicity in Babies

scientific article published on 27 February 2016

A novel ceftazidime/avibactam, rifabutin, tedizolid and moxifloxacin (CARTM) regimen for pulmonary Mycobacterium avium disease

scientific article published on September 2017

A programme to create short-course chemotherapy for pulmonary Mycobacterium avium disease based on pharmacokinetics/pharmacodynamics and mathematical forecasting

scientific article published on September 2017

Amikacin Optimal Exposure Targets in the Hollow-Fiber System Model of Tuberculosis

scientific article published on 25 July 2016

Antibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis

scientific article published on 27 November 2017

Ceftazidime-avibactam has potent sterilizing activity against highly drug-resistant tuberculosis.

scientific article published on 30 August 2017

Concentration-Dependent Synergy and Antagonism of Linezolid and Moxifloxacin in the Treatment of Childhood Tuberculosis: The Dynamic Duo.

scientific article

Drug Concentration Thresholds Predictive of Therapy Failure and Death in Children With Tuberculosis: Bread Crumb Trails in Random Forests

scientific article

Efficacy Versus Hepatotoxicity of High-dose Rifampin, Pyrazinamide, and Moxifloxacin to Shorten Tuberculosis Therapy Duration: There Is Still Fight in the Old Warriors Yet!

scientific article published on 01 November 2018

Ethambutol optimal clinical dose and susceptibility breakpoint identification by use of a novel pharmacokinetic-pharmacodynamic model of disseminated intracellular Mycobacterium avium

scientific article published on 15 March 2010

Failure of the Amikacin, Cefoxitin, and Clarithromycin Combination Regimen for Treating Pulmonary Mycobacterium abscessus Infection

scientific article published on 25 July 2016

Failure of the azithromycin and ethambutol combination regimen in the hollow-fibre system model of pulmonary Mycobacterium avium infection is due to acquired resistance

scientific article published on September 2017

Linezolid Dose That Maximizes Sterilizing Effect While Minimizing Toxicity and Resistance Emergence for Tuberculosis

scientific article published on 5 June 2017

Linezolid as treatment for pulmonary Mycobacterium avium disease

scientific article published on September 2017

Linezolid for Infants and Toddlers With Disseminated Tuberculosis: First Steps

scientific article

Meta-analyses and the evidence base for microbial outcomes in the treatment of pulmonary Mycobacterium avium-intracellulare complex disease

scientific article published on September 2017

Moxifloxacin pharmacokinetics/pharmacodynamics and optimal dose and susceptibility breakpoint identification for treatment of disseminated Mycobacterium avium infection

scientific article published on 12 April 2010

Moxifloxacin's Limited Efficacy in the Hollow-Fiber Model of Mycobacterium abscessus Disease

scientific article published on 11 April 2016

Multiparameter Responses to Tedizolid Monotherapy and Moxifloxacin Combination Therapy Models of Children With Intracellular Tuberculosis

article

Once-a-week tigecycline for the treatment of drug-resistant TB

scientific article published on 01 June 2019

Optimal Clinical Doses of Faropenem, Linezolid, and Moxifloxacin in Children With Disseminated Tuberculosis: Goldilocks

scientific article

Systematic review and meta-analyses of the effect of chemotherapy on pulmonary Mycobacterium abscessus outcomes and disease recurrence

scientific article published on 14 August 2017

Tedizolid is highly bactericidal in the treatment of pulmonary Mycobacterium avium complex disease

scientific article published on September 2017

The antibiotic resistance arrow of time: efflux pump induction is a general first step in the evolution of mycobacterial drug resistance

scientific article

The discovery of ceftazidime/avibactam as an anti-Mycobacterium avium agent

scientific article published on September 2017

Thioridazine as Chemotherapy for Mycobacterium avium Complex Diseases

scientific article published on 23 May 2016

Tigecycline Is Highly Efficacious against Mycobacterium abscessus Pulmonary Disease

scientific article published on 29 February 2016

Transformation Morphisms and Time-to-Extinction Analysis That Map Therapy Duration From Preclinical Models to Patients With Tuberculosis: Translating From Apples to Oranges

scientific article published on 01 November 2018

Paulina is supported by:

About Paulina

Help